Call provider(650) 563-8696

Rapamycin Bioavailability Panel

$

Targeted sirolimus blood-level testing for rapamycin absorption, clearance, and dose-timing decisions

Single-analyte sirolimus test for rapamycin users choosing peak, trough, or mid-cycle timing for dose insight

Biomarkers

1 analyte (sirolimus blood serum)

Collection

In-lab

Turnaround

Typically 2-3 weeks after lab draw

Price

$25

Physician reviewed

Yes

Membership

Not required

About

Rapamycin Bioavailability Panel is a single-analyte sirolimus blood serum test for users already taking rapamycin and trying to understand absorption, clearance, or dose timing. The patient chooses the draw window: peak around 3-4 hours post-dose, trough before the next dose, or mid-cycle around 72 hours post-dose. Results return in 2-3 weeks with physician review tied to the selected timing window. This is a monitoring tool, not a broad longevity screen.

A Healthspan physician reviews the sirolimus result in light of the selected timing window, reported dose, frequency, and goals. The interpretation is geared toward rapamycin protocol decisions instead of general health screening.

What to Know

Signature approach

The panel is built around timing. Peak testing shows absorption, trough testing shows clearance before the next dose, and mid-cycle testing shows how quickly the drug is moving through the body between doses. Physician review connects the result to dose, frequency, brand, and goals, which is more useful for weekly longevity dosing than a generic sirolimus value alone.

What sets it apart

  • Purpose-built rapamycin monitoring. The test answers absorption and clearance questions for weekly sirolimus users. - Three timing windows. Peak, trough, and mid-cycle options map to different dosing decisions. - Low-cost repeatability. At $25 the panel is sized for follow-up after early doses or medication changes.

Before You Order

  • Use case. Best for users already taking rapamycin who need a sirolimus level for dose decisions.
  • Single analyte. It measures sirolimus only; use another panel for metabolic, lipid, hormone, CBC, inflammation, or organ-function context.
  • Timing matters. Book the draw to match the selected peak, trough, or mid-cycle window.
  • Turnaround. Results usually take 2-3 weeks.
  • State availability. Unavailable in NY, NJ, and RI.

What's tested

What's included

Physician ReviewResults DashboardPersonalized Recommendations

Biomarker categories

Pharmacokinetics (Drug Level)

1 marker
Sirolimus, Blood Serum

What’s not included

Outside the panel: metabolic markers, lipids, hormones, inflammation markers, CBC, organ function, biological-age scoring, and a comprehensive health baseline. It is a rapamycin-monitoring test only.

Reference ranges methodology

There is no single public longevity target range for weekly rapamycin use. Healthspan interprets the value against the selected timing window, dose, frequency, and goal, while transplant trough ranges are designed for a different sustained-immunosuppression use case.

Pricing

Starting at

$25

One sirolimus blood serum draw at the selected timing window, physician-reviewed interpretation, dashboard result, partner-lab collection, and HSA/FSA eligibility.

Panel details

Rapamycin Bioavailability Panel

1 biomarker · In Lab blood draw at 2,000+ partner lab locations

$25

Sirolimus blood serum level at one timing window (peak, trough, or mid-cycle); physician-reviewed personalized report; results dashboard; free shipping

Expected first-year cost

$25/yr - $75/yr

In practiceReal-world pricing notes, add-ons, and coverage limits.

One-time price: $25 for one sirolimus blood-level test and physician-reviewed interpretation. Healthspan recommends testing after the first 2-3 doses and again after dose, brand, or frequency changes, so a first year on a stable protocol may involve 1-3 draws, roughly $25 - $75 HSA/FSA eligible. Confirm at checkout that the purchase is the one-time sirolimus panel if any monthly wording appears in the interface.

How it works

  1. 1

    Pick your timing window

    Decide whether the draw should land at peak (3-4 hours after a dose), trough (just before the next dose), or mid-cycle (72 hours post-dose). The window you pick determines what the result tells you — absorption, clearance, or metabolism rate.

  2. 2

    Book your lab draw

    Schedule the draw at one of 2,000+ partner locations nationwide. The appointment time has to line up with your dosing schedule and the window you chose, so book around your dose, not the other way around.

  3. 3

    In-lab blood draw

    Drop in for a quick serum draw. No fasting required, but avoid strenuous exercise in the 12 hours before.

  4. 4

    Physician-reviewed result

    Your sirolimus level returns in 2-3 weeks with a physician interpretation tied to the timing window you selected. Plan to retest after the first 2-3 doses and again after any change in dose, brand, or frequency.

US availability

Availability

Not available in 3 US regions

Available in the other 47 US regions.

47

Exceptions

  • New Jersey

    State regulations restrict DTC lab testing

  • New York

    State regulations restrict DTC lab testing

  • Rhode Island

    State regulations restrict DTC lab testing

Frequently asked questions

Who should order this?

Users already taking rapamycin who want sirolimus blood-level data for absorption, clearance, or dose-timing decisions.

What do peak, trough, and mid-cycle mean?

Peak is around 3-4 hours after dosing, trough is before the next dose, and mid-cycle is around 72 hours after dosing. Each answers a different dosing question.

Is this a full longevity panel?

No. It measures sirolimus only. Use a broader panel for metabolic, lipid, hormone, CBC, inflammation, or organ-function context.

How often should I test?

Healthspan suggests after the first 2-3 doses and again after changes in dose, brand, or frequency.

Where is it available?

At partner labs in 47 states, excluding New York, New Jersey, and Rhode Island.

Other tests from Healthspan

Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.